Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Immpact Bio
AddedFeb 15, 2024
UpdatedJun 18, 2026
Immpact Bio

Immpact Bio

Series B

ImmPACT Bio: Innovating transformative CAR-T cell therapies for advanced cancer patients.

HQ
Camarillo, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize cancer treatment, ImmPACT Bio focuses on developing transformative CAR-T cell therapies for patients with advanced cancer who have exhausted other treatment options. The company's vision is to harness cutting-edge science to create life-saving treatments. ImmPACT Bio offers a pipeline of innovative therapies, including CD19/20 bispecific and TGF-β targeted treatments, aimed at improving patient outcomes in the oncology market.

Notable figures associated with ImmPACT Bio include leading scientists and industry experts who drive its research and development efforts. The company has attracted significant investment from prominent venture capital firms, underscoring confidence in its potential. ImmPACT Bio's key achievements include advancing multiple therapies into clinical trials, demonstrating promising results in early studies, and establishing strategic partnerships. Its impact lies in offering new hope to cancer patients through pioneering CAR-T cell therapies.

Immpact Bio - Similar Companies

AffyImmune Therapeutics logo

AffyImmune Therapeutics

affyimmune.com

A2 Biotherapeutics logo

A2 Biotherapeutics

a2bio.com

Inceptor Bio logo

Inceptor Bio

inceptor.bio

INmune Bio logo

INmune Bio

inmunebio.com

Cartography Biosciences logo

Cartography Biosciences

cartography.bio

Outpace Bio logo

Outpace Bio

outpacebio.com

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

Tactiva Therapeutics logo

Tactiva Therapeutics

ImmunityBio logo

ImmunityBio

immunitybio.com

Iovance Biotherapeutics logo

Iovance Biotherapeutics

iovance.com

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Chimera Bioengineering logo

Chimera Bioengineering

chimera.bio

3T Biosciences logo

3T Biosciences

3tbiosciences.com

Cellective BioTherapy logo

Cellective BioTherapy

Aleta Biotherapeutics logo

Aleta Biotherapeutics

aletabio.com

Immpact Bio - Quick Facts

Who are Immpact Bio's competitors?

Companies similar to Immpact Bio include AffyImmune Therapeutics, A2 Biotherapeutics, Inceptor Bio and INmune Bio.

When was Immpact Bio founded?

Immpact Bio was founded in 2017.

Where is Immpact Bio's headquarters located?

Immpact Bio's headquarters is located in Camarillo, CA, US.

When was Immpact Bio's last funding round?

Immpact Bio's most recent funding round was for $111M (USD) in January 2022.

How much has Immpact Bio raised to-date?

As of Jan 20, 2022, Immpact Bio has raised a total of $129M (USD).

How many employees does Immpact Bio have?

Immpact Bio has 105 employees as of Feb 5, 2024.

Immpact Bio - Classification

Industry
  • Therapeutics
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • CAR T-Cell Therapy
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified